This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal…
40 publications
2025
Ear, nose, & throat journal
PubMed • Publisher's site2025
International Forum of Allergy & Rhinology
Publisher's site2025
Chemical Senses
Publisher's site2025
International Forum of Allergy & Rhinology
Publisher's site2024
Journal of neurological surgery. Part B, Skull base
PubMed • Publisher's site